Intermittent tri-weekly docetaxel plus bicalutamide in patients with castration-resistant prostate cancer: a single-arm prospective study using a historical control for comparison

Whether continuous docetaxel (DTX) chemotherapy offers an advantage over intermittent therapy for castration-resistant prostate cancer (CRPC) is unknown. In this study, we evaluated the efficacy, toxicity and quality of life (QoL) of intermittent tri-weekly DTX with bicalutamide in CRPC. Forty-two p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Li, Yun-Fei, Zhang, Shao-Feng, Zhang, Tao-Tao, Li, Lei, Gan, Wei, Jia, Hong-Tao, Xie, Sheng, Ji, Hui-Hua, He, Da-Lin
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854057/
https://ncbi.nlm.nih.gov/pubmed/23955552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aja.2013.89
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados